General Prognostics
PrivateLast Round
Seed
Nov 12, 2024
Total Funding Raised
$3.25M
Company Overview
General Prognostics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Seed round in November 2024.
General Prognostics is a healthcare technology company that provides an AI-based platform for remote chronic disease management through bloodless blood tests.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Health IoT, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
General Prognostics Comparables
Compare General Prognostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bodyport | 78% | |
| Myia Health | 78% | |
| AIKON Health | 77% |
For institutional investors. Book with your work email.
General Prognostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 12, 2024 | ||||
| Seed | Sep 30, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
General Prognostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NEC X | Seed |
| D4V (Design for Ventures) | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors grew 115% MoM, from 2.3K to 5K.
For institutional investors. Book with your work email.
General Prognostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about General Prognostics's valuation, stock price, and market status.
Is General Prognostics a public or private company?
General Prognostics is a private company.
What is the current stock price of General Prognostics?
General Prognostics is a private company, so its shares have no public market price. Caplight tracks General Prognostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is General Prognostics worth (valuation)?
Valuation information for General Prognostics is not publicly available.
Can I buy General Prognostics stock?
General Prognostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was General Prognostics's last funding round?
General Prognostics's most recent funding round was Seed on November 12, 2024.
Who are the main investors in General Prognostics?
Key investors in General Prognostics include NEC X, D4V (Design for Ventures).
Will General Prognostics IPO soon?
No public IPO plans have been announced for General Prognostics.
How can I track General Prognostics secondary market activity?
Caplight tracks bids, offers, and trades in General Prognostics's shares on secondary markets.